Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PHEZ | ISIN: SE0012558617 | Ticker-Symbol: N/A
Frankfurt
26.05.25 | 08:10
0,007 Euro
0,00 % 0,000
1-Jahres-Chart  (nicht börsennotiert)
LIPIDOR AB Chart 1 Jahr

Aktuelle News zur LIPIDOR

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.06.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025434The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY...
► Artikel lesen
26.05.Delisting of Lipidor AB from Nasdaq First North Growth Market195On May 26, 2025, Lipidor AB was declared bankrupt by the Stockholm District Court. According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist...
► Artikel lesen
26.05.XFRA L7R: AUSSETZUNG/SUSPENSION103DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILLIPIDOR AB L7R SE0012558617...
► Artikel lesen
26.05.Suspension of Trading in Lipidor AB at FNSE1542025-05-26T06:33:44Z Suspension At Trading Venue FNSE Due to Non Disclosure Of Inside Information About The Issuer Or Financial Instrument Ongoing: True Comments: Nasdaq Stockholm has, to the extent...
► Artikel lesen
LIPIDOR Aktie jetzt für 0€ handeln
25.05.Lipidor AB: Lipidor applies for bankruptcy170STOCKHOLM, Sweden, 25th May 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the Company's board has resolved to file for bankruptcy on behalf of the Company. The...
► Artikel lesen
24.05.Lipidor AB: Lipidor announces today negative results from the company's Phase III clinical study of AKP02G2 for psoriasis98STOCKHOLM, Sweden, 24th May 2025 - (Nasdaq First North: LIPI) reports negative results from a Phase III clinical study of the AKP02G2 cutaneous spray for mild to moderate plaque psoriasis. The study...
► Artikel lesen
19.05.Lipidor AB: Lipidor announces database lock in its Phase III clinical study of the psoriasis candidate AKP02G2115STOCKHOLM, Sweden, 19th May 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the company's Phase III study of AKP02G2 for the treatment of psoriasis has reached...
► Artikel lesen
17.03.Lipidor AB: Lipidor announces all patients enrolled in ongoing Phase III study140STOCKHOLM, Sweden, 17th March 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that all patients in the ongoing Phase III study for the drug candidate AKP02G2 have been...
► Artikel lesen
28.02.Lipidor AB: Lipidor AB (publ) publishes year-end report for 2024207STOCKHOLM, Sweden, 28th February 2025 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2024. The report is available...
► Artikel lesen
21.01.Lipidor AB: Lipidor announces half of patients enrolled in ongoing Phase III study503STOCKHOLM, Sweden, 21st January 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that half of the patients in the ongoing Phase III study for the drug candidate AKP02G2...
► Artikel lesen
20.11.24Lipidor AB: Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025"153STOCKHOLM, Sweden, 20 November 2024 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today provides an update on the business from CEO Ola Holmlund, also announcing a company presentation...
► Artikel lesen
28.08.24Lipidor AB: Lipidor AB (publ) publishes interim report for Q2 2024135STOCKHOLM, Sweden, 28 August 2024 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the period January - June 2024. The report is available on the...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten